Your browser doesn't support javascript.
loading
A RT-qPCR system using a degenerate probe for specific identification and differentiation of SARS-CoV-2 Omicron (B.1.1.529) variants of concern.
Jessen, Randi; Nielsen, Line; Larsen, Nicolai Balle; Cohen, Arieh Sierra; Gunalan, Vithiagaran; Marving, Ellinor; Alfaro-Núñez, Alonzo; Polacek, Charlotta; Fomsgaard, Anders; Spiess, Katja.
  • Jessen R; Test Center Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Nielsen L; Test Center Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Larsen NB; Test Center Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Cohen AS; Test Center Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Gunalan V; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Marving E; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Alfaro-Núñez A; Department of Clinical Biochemistry, Naestved Hospital, Naestved, Denmark.
  • Polacek C; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Fomsgaard A; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Spiess K; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
PLoS One ; 17(10): e0274889, 2022.
Article en En | MEDLINE | ID: mdl-36197885
ABSTRACT
Fast surveillance strategies are needed to control the spread of new emerging SARS-CoV-2 variants and gain time for evaluation of their pathogenic potential. This was essential for the Omicron variant (B.1.1.529) that replaced the Delta variant (B.1.617.2) and is currently the dominant SARS-CoV-2 variant circulating worldwide. RT-qPCR strategies complement whole genome sequencing, especially in resource lean countries, but mutations in the targeting primer and probe sequences of new emerging variants can lead to a failure of the existing RT-qPCRs. Here, we introduced an RT-qPCR platform for detecting the Delta- and the Omicron variant simultaneously using a degenerate probe targeting the key ΔH69/V70 mutation in the spike protein. By inclusion of the L452R mutation into the RT-qPCR platform, we could detect not only the Delta and the Omicron variants, but also the Omicron sub-lineages BA.1, BA.2 and BA.4/BA.5. The RT-qPCR platform was validated in small- and large-scale. It can easily be incorporated for continued monitoring of Omicron sub-lineages, and offers a fast adaption strategy of existing RT-qPCRs to detect new emerging SARS-CoV-2 variants using degenerate probes.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article